five

Hyperoxia impairs iPSC derived endothelial cells and drives an atherosclerosis-like transcriptional phenotype. Hyperoxia impairs iPSC derived endothelial cells and drives an atherosclerosis-like transcriptional phenotype

收藏
NIAID Data Ecosystem2026-05-01 收录
下载链接:
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1095818
下载链接
链接失效反馈
官方服务:
资源简介:
Induced pluripotent stem cells (iPSCs) directed to endothelial identity (iPSC-ECs) lose expression of key identity markers under standard in vitro conditions, limiting their clinical applications. We examined iPSC-ECs at late passage (>2 weeks) under hyperoxic (21%)conditions with single cell RNA sequencing Overall design: Y6 pluripotent stem cells were directed to endothelial identity by treatment with CHIR99021, a GSK3 inhibitor, as well as BMP4 for 3 days, followed by VEGFa and forskolin treatment for 2 days according to the protocol described by Cowen et al 2014, Nature Cell Biology DOI 10.1038/ncb3205. Then, cells were purified using CD144 magnetic beads, and were subsequently cultured for two weeks at atmospheric oxygen level (21%) in a conventional cell culture incubator before harvest and analysis by scRNAseq

诱导多能干细胞(induced pluripotent stem cells,iPSCs)定向分化为内皮细胞表型(iPSC-ECs)后,在标准体外培养条件下会丢失关键身份标记物的表达,这限制了其临床应用。我们针对传代晚期(培养时长超过2周)的iPSC-ECs,在高氧(21%氧浓度)条件下开展了单细胞RNA测序(single cell RNA sequencing,scRNAseq)分析。 实验整体设计如下:参照Cowen等人2014年发表于《Nature Cell Biology》(DOI: 10.1038/ncb3205)的实验方案,首先使用GSK3抑制剂CHIR99021与骨形态发生蛋白4(BMP4)处理Y6多能干细胞3天,将其定向诱导为内皮细胞表型;随后采用血管内皮生长因子A(VEGFa)与福司可林(forskolin)继续处理2天。之后通过CD144磁珠对诱导得到的细胞进行纯化,并在常规细胞培养箱中以常压氧浓度(21%)继续培养两周,最后收集细胞并通过scRNAseq完成检测分析。
创建时间:
2024-04-03
二维码
社区交流群
二维码
科研交流群
商业服务